TITLE

Corroborative Study Confirmed That Adding Enfuvirtide to an Optimized Antiretroviral Regimen Benefited Patients with Multidrug-Resistant HIV Infection

AUTHOR(S)
Lorber, Bennett
PUB. DATE
December 2004
SOURCE
Annals of Internal Medicine;12/7/2004, Vol. 141 Issue 11, p878
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information on papers related to infectious diseases in Europe and Australia. The paper "Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia," by A. Lazzarin, B. Clotet, D. Cooper, et al. confirmed that adding enfuvirtide to an optimized antiretroviral regimen benefited patients with multidrug-resistant HIV infection. Researchers showed that the addition of new antifusion agent to an optimized regimen provided significant viral load suppression and immunologic benefit after 24 weeks in people with very advanced disease who had received multiple antiretroviral agents and in whom therapy was failing.
ACCESSION #
15279615

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics